• LAST PRICE
    0.7594
  • TODAY'S CHANGE (%)
    Trending Down-0.0231 (-2.9521%)
  • Bid / Lots
    0.7595/ 1
  • Ask / Lots
    0.7825/ 1
  • Open / Previous Close
    0.7800 / 0.7825
  • Day Range
    Low 0.7500
    High 0.7800
  • 52 Week Range
    Low 0.4201
    High 1.8800
  • Volume
    15,449
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.7825
TimeVolumeNLSP
09:52 ET1000.78
10:03 ET30000.7799
10:06 ET2500.78
10:46 ET10000.7701
10:48 ET7000.76
10:51 ET1560.7602
11:00 ET11000.77
11:02 ET20250.77
11:31 ET1320.78
11:36 ET1510.78
12:56 ET1000.78
01:21 ET1500.7613
01:35 ET1000.7704
01:50 ET4000.77
02:06 ET2000.7625
02:26 ET31830.76
02:27 ET9970.7599
03:00 ET2000.75
03:54 ET10000.7594
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNLSP
NLS Pharmaceutics AG
25.4M
-0.9x
---
United StatesCHEK
Check Cap Ltd
25.5M
-0.2x
---
United StatesBIXT
Bioxytran Inc
25.2M
-7.2x
---
United StatesFBRX
Forte Biosciences Inc
24.9M
-0.6x
---
United StatesGWLL
Goldenwell Biotech Inc
24.8M
-24.5x
---
United StatesAURX
Nuo Therapeutics Inc
25.8M
-7.1x
---
As of 2023-09-28

Company Information

NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.

Contact Information

Headquarters
The Circle 6ZUERICH, Switzerland 8058
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Ronald Hafner
Chief Executive Officer, Director
Alexander Zwyer
Chief Scientific Officer
Eric Konofal
Chief Medical Officer and Global Head of Research and Development
George Apostol
Independent Director
Myoung-Ok Kwon

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$25.4M
Revenue (TTM)
$0.00
Shares Outstanding
32.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.88
Book Value
$0.10
P/E Ratio
-0.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.